Sponsor or institution
Clinical trials and research at Acepodia Biotech, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Acepodia Biotech, Inc. that are recruiting, at sites in 4 countries (most in United States (2), China (1), Japan (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
ACE1831 cell therapy for safety, effectiveness, and persistence in people with IgG4-related disease
This trial will test ACE1831, an off-the-shelf gamma delta T cell therapy from healthy donors, to see if it is safe and helps adults with active IgG4-related disease.
-
Treatment of advanced solid tumors using ACE2016 cell therapy
This study is testing a new cell therapy called ACE2016 to see if it can help people with advanced solid tumors that have not improved with other treatments.
Quick answers
How many clinical trials run by Acepodia Biotech, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (1 trial), Japan (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.